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0929-6441/ª 2014, Elsevier Taiwan LLBackground: Real-time ultrasound (US) elastography (USE) assesses lesion stiffness and was re-
ported as markedly accurate in thyroid nodule evaluation. The aim of this study was to validate
the effectiveness of head and neck surgeon-performed USE in the evaluation of thyroid nod-
ules.
Methods: From January 2011 to November 2013, 308 patients with thyroid nodules who
received traditional US, USE, and US-guided cytology were reviewed. The nodules with
cytology reports that revealed Bethesda cytology levels of Thy 2, Thy 5, and Thy 6 were
collected. The characteristics of traditional US and USE were analyzed.
Results: Univariate analysis revealed that a set of characteristics including a larger transverse
diameter, taller-than-wide shape, margins, heterogeneous echotexture, microcalcification,
predominately solid echo structure, marked intranodular vascular pattern and USE (an elasto-
graphy score of III/IV vs. I/II) differed significantly between malignancy and benignity
(p < 0.05). Stepwise multivariate logistic regression analysis showed that a taller-than-wide
shape, microcalcification, and USE were independent, significant factors in predicting malig-
nant nodular disease (p < 0.05)
Conclusion: The results support the hypothesis that USE is an independent factor in deter-
mining malignant thyroid nodules.
ª 2014, Elsevier Taiwan LLC and the Chinese Taipei Society of Ultrasound in Medicine.
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Thyroid nodules are frequently found in clinical practice,
and their prevalence in the general population is approxi-
mately 4e7% as identified by palpation [1]. By identification
by ultrasound (US), 27e67% of adults have thyroid nodules,
and nearly 30e60% of the population has thyroid nodules at
autopsy [1,2]. Among thyroid nodules, approximately
5e12% are found to be malignant [3,4]. US examination is
the preferred imaging method for the differential diagnosis
of thyroid nodules and neck masses. Most thyroid sonogra-
phy has previously been performed by radiologists [5,6] or
endocrinologists [7]; increasingly, a greater number of pa-
tients are being referred to otolaryngology head and neck
(H&N) surgeons for the evaluation of neck masses including
thyroid nodules. Hence, identifying the familiar charac-
teristics of malignant thyroid nodules to differentiate ma-
lignant and benign thyroid nodules before US-guided fine-
needle aspiration (US-FNA) is important for H&N surgeons.
Many physicians refer patients with thyroid nodules to
H&N surgeons for surgical treatment because of the
detection of growth, a decision that is made by comparing
ultrasound thyroid measurements over time. Although US
comparison of volume change is reliable, there is variation
in the reliability variation resulting from different opera-
tors, biological variation in tumors, and examination tech-
nique limitations [8]. US-FNA cytology is the initial
investigation of choice rather than serial follow-up for a
suspected malignant thyroid nodule.
US-FNA is invasive, and multiple nodules are common. It
is appropriate to select the most suspicious nodule for
aspiration. Certain conventional sonographic characteris-
tics facilitate selecting a thyroid nodule for US-FNA. US
elastography (USE), first described for thyroid lesions in
2005, has been reported as a tool that might improve the
management of thyroid lesions [9].
Elastography consists of real-time evaluation [(real-time
USE (RTE)] of an area of interest during the application of
external force by an echographic probe. Software monitors
the tissue displacement that is displayed by a color scale in
accordance with the nodular and extranodular hardness.
Thyroid cancer typically appears as a hard, firm lesion, and
several studies have reported a high specificity and sensi-
tivity of RTE in predicting thyroid cancer [10]. The diag-
nostic accuracy of this imaging technique has been
reported as variable. The inconsistent results can probably
be explained by limitations in most of these studies as
follows: a small series of patients; previous selection;
retrospective design; a single examiner; and lack of stan-
dardization of the procedure.
Because of the inconsistent results, the aim of this study
was to validate prospectively the diagnostic accuracy of
conventional US and RTE by H&N surgeons to detect thyroid
cancer in a consecutive series of patients.Materials and methods
Institutional Review Board (IRB) approval for this study was
obtained [Far Eastern Memorial Hospital [(FEMH) IRB
102110-E]. Patients with thyroid nodules wereconsecutively enrolled in this prospective study, and all the
participants were followed for at least 6 months.
Patients with thyroid nodules who visited the Depart-
ment of Otolaryngology of the Far Eastern Memorial Hos-
pital in Taipei, Taiwan from July 2011 to July 2013 were
enrolled in the study. US-FNA examinations were per-
formed, and the cytological diagnoses were made in
accordance with the following six diagnostic groups of the
Bethesda system: Thy 1 e nondiagnostic; Thy 2 e benign;
Thy3 e atypia; Thy 4 e follicular lesion; Thy 5 e suspicious
of malignancy; and Thy 6 e diagnostic of malignancy. The
cytology results with Bethesda system ratings of 2, 5, and 6
were recruited for further analysis.Thyroid B-mode US, power Doppler US, and USE
The US examinations were performed by two sonographers
(L.J.L. and W.C.L.) using a Toshiba Aplio MX (Toshiba
Medical Systems, Tokyo, Japan) with a 7e18 MHz broad-
band linear array transducer. All the patients first under-
went a thorough neck examination using grayscale
ultrasound and power Doppler ultrasound. The settings for
power Doppler sonography were set for high sensitivity with
a low wall filter to allow for the detection of vessels with
low blood flow. The color gain was increased until back-
ground noise appeared and was then reduced until the
noise was suppressed, thus ensuring maximum sensitivity
according to the Bude and Rubin [11] description.
The morphologic sonographic parameters and vascular
features were thoroughly evaluated and recorded by the
Marosis PACS system (Marotech Inc, Seoul, South Korea) for
all the thyroid nodal lesions in each patient. Each thyroid
nodule was first assessed with grayscale sonography for the
morphologic parameters in the horizontal section. The
anteroposterior (AP) diameter, transverse (TR) diameter,
and diameter ratio of the AP to TR dimension (AP/TR ratio)
were measured. The echo structure was categorized as a
predominantly solid component or mixed cyst. Nodule
echogenicity included hypoechoic (when a nodule is hypo-
echoic relative to the thyroid parenchyma), isoechoic
(when a nodule has the same echogenicity as that of the
thyroid parenchyma), and hyperechoic (when a nodule is
echogenic relative to the thyroid parenchyma). The nodule
margin was defined as regular or irregular. The micro-
calcification was distinguished by its presence or absence.
The internal echotexture was divided into heterogeneity or
homogeneity. The vascular patterns were surveyed by
power Doppler sonography and categorized as the avascular
or peripheral type versus the intranodular type.
During the elastographic procedure, the USE images
were displayed superimposed and adjacent to the grayscale
ultrasounds as a dual-panel image. Next, the sonographers
followed light pressure compression with repeated
decompression until nearly the identical size and color
distribution of the region of interest in several consecutive
images was obtained. The USE images generated were
color-coded with respect to the selected target areas, such
that blue indicated the maximum stiffness tissue, green
and yellow indicated the intermediate stiffness tissue, and
red indicated the softer tissue. The appropriate compres-
sion was determined by manual adjustments including that
Fig. 1 A 36-year-old man with a right thyroid nodule, measuring 0.95 cm  0.93 cm (marked in the circle). Ultrasound elas-
tography reveals elasticity score of I. Ultrasound-guided fine-needle aspiration revealed a Bethesda system level of Thy 2, and a
benign thyroid nodule is impressed.
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mediate strain pattern as opposed to an appearance of
under- or overcompression. The sonographers orientated
the direction of compression along the radiation axis and
avoided out-of-plane motion. The USE of each patient was
performed by one observer, and these elastographic images
were saved as bitmap files on a hard disk by the research
nurse.
The USE score was assessed based on a color scale, with
blue being correlated with hard tissue, red with soft tissue,
and green with tissue of intermediate hardness. The nod-
ules were classified into the following four elasticity scores
(ES): ES I, a prevalence of red and green color; ES II, a
prevalence of green in more than 50% of the nodule; ES III, a
prevalence of blue in at least 50% of the nodule; and ES IV, a
prevalence of blue in at least 75% of the nodule. Figs. 1e4
illustrate the RTE score assessed in the study.
US-FNA cytology
FNA biopsy was performed using the free hand technique,
by positioning the array probe parallel to the needle for the
guidance and placement of a 22-gauge needle within the
nodule that was the most suspicious of being malignant.
Statistical analyses
The conventional US, Color-flow Doppler (CFD), and USE
characteristics were compared by a c2 test or Fisher’s
exact test, as appropriate. Univariate and multivariatelogistic regression was performed; the odds ratio and 95%
confidence interval were used to evaluate the association
of several parameters with malignancy. The statistical
significance was set at p < 0.05. The statistical analyses
were performed using STATA software, version 12.0 (Sta-
taCorp. 2011. Stata Statistical Software: Release 12; Sta-
taCorp LP, College Station, TX, USA).Results
The data regarding 308 thyroid nodules from 308 patients
[236 women/72 men; mean  standard deviation (SD) age,
49.1  13.7 years; range, 20e90 years] were assessed.
There were 267 (86.7%) benign and 41(13.3%) malignant
nodules recruited. The mean AP diameter of the nodules
examined was 14.6 mm (3.2e84.0 mm, SD 8.8), and the
mean TR diameter of the nodules examined was 19.8 mm
(4.6e88.0 mm, SD 11.6). The echostructure was predomi-
nately solid in 179 nodules (58.1%) and predominately cystic
in 129 (41.9%). The echogenicity was hypo in 251 nodules
(81.5%) and iso in 57 (18.5%) nodules. The echostructure
was heterogeneous in 143 nodules (46.4%) and homoge-
neous in 165 nodules (53.6%). Microcalcifications were
observed in 70 cases (22.7%). In 47 nodules, the AP/TR ratio
was 1 (15.26%). Finally, a pattern of marked internal
vascularization was observed in 83 nodules (27.0%). There
were 77 (25.0%) nodules classified as ES I/II.
The comparisons of the various sonographic parameters
in malignant and benign nodular disease are shown in
Table 1. Univariate analysis revealed that a larger
Fig. 2 A 47-year-old female patient with a solitary solid nodule over the right lobe, measuring 0.69 cm  1.02 cm in diameter.
Ultrasound elastography reveals an elasticity score of II. Ultrasound-guided fine-needle aspiration revealed a Bethesda system level
of Thy 2, and a benign thyroid nodule is impressed.
Fig. 3 A 48-year-old male patient with a left thyroid nodule, measuring 0.56 cm  0.55 cm. Ultrasound-guided fine-needle
aspiration cytology revealed a suspicion for a papillary carcinoma (Bethesda system level, Thy 5); ultrasound elastography reveals
an elasticity score of III.
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Fig. 4 A 49-year-old female patient with multiple thyroid nodules. One nodule over the left lobe measured 0.77 cm  0.75 cm.
The B-mode ultrasound (US) revealed a hypoechoic solid nodule. US-guided fine-needle aspiration cytology and final pathology
showed papillary carcinoma. US elastography reveals an elasticity score of IV.
Evaluation of Thyroid Nodules 149transverse diameter, a taller-than-wide shape (AP/TR  1),
margins, a heterogeneous echotexture, microcalcification,
a predominately solid echo structure, a markedly intra-
nodular vascular pattern, and elastography pattern (ES III/
IV) differed significantly between malignancy and benignity
(p < 0.05).
These significant predictors were incorporated into the
univariate age- and sex-adjusted and multivariate logistic
regression analyses, and the results are shown in Table 2.
The stepwise multivariate logistic regression analysis
showed that taller than wide, microcalcification, and
elastography (ES III/IV) were independent, significant fac-
tors in predicting malignant nodular disease (p < 0.05;
Table 2).Discussion
Use of ultrasound to examine thyroid nodules has a long
history. The sonographic findings suggestive of a malignant
thyroid nodule include a taller-than-wide shape, blurred
margins, marked hypoechogenicity, heterogeneous echo
texture, microcalcification, and a predominately solid
echo-structure. Marked intranodule vascularity in color
Doppler is another predictor. Currently, an increasing
number of H&N surgeons use clinical ultrasound.
USE is a relative new technology in thyroid nodule
evaluation. Since 2005, elastography has been used for
thyroid nodules evaluation [9]. Elastography is classified
into quasistatic elastography and shear wave elastography
(SWE) prototypes. Quasistatic elastography, designated asreal-time elastography, allows comparison of tissue elas-
ticity, between a lesion and normal tissue, that is induced
by external probe compression while a shear wave is
emitted by the probe, propagated through the tissue and
finally distorted by the tissue heterogeneities. The SWE of
tissue can be mapped quantitatively from this propagation
motion image and shown on a screen [12].
Several studies have reported the utility of USE for the
evaluation of thyroid nodules. One recent meta-analysis
concluded that USE appears to be a safe and effective
technique for the clinical diagnosis of thyroid nodules [13].
Some authors have suggested that USE is not superior to
grayscale ultrasound in predicting malignant thyroid nod-
ules [14]. Previous USE was predominantly performed by
physicians, and no reports from otolaryngologist H&N sur-
geons have been reported. Our report is the first validation
of the use of elastography in thyroid nodule detection by
H&N surgeons.
Ever more H&N surgeons use ultrasound to exam the
neck, including the thyroid glands and other soft tissue
lesions. Preoperative ultrasound has high sensitivity and
specificity in diagnosing both malignant thyroid nodule and
lateral cervical lymph node metastases [15]. Therefore,
ultrasound of the neck is helpful for H&N surgeons prior to
thyroid surgery. Recently, the American Academy of Oto-
laryngologyeHead and Neck Surgery and the American
Institute of Ultrasound in Medicine have collaboratively
developed a guideline for H&N ultrasound [16]. In our
opinion, head and neck surgeons could be good sonogra-
phers to perform the ultrasound and USE for the thyroid
nodules.
Table 1 Distribution of benign, malignant, and suspicious malignant thyroid nodules on conventional US, color-flow Doppler,
and real-time USE.
Cytologic diagnosis Benign (Bethesda system
Thy 2; n Z 267)
Suspicious and diagnostic
of malignancy (Bethesda system
Thy 5/6, n Z 41)
p
Age 48.9  13.4 50.0  16.0 0.63
Sex (F/M) 207/60 29/12 0.34
Number (multiple/single) 33/11 203/61 0.78
AP diameter (mm) 14.7  8.9 13.7  7.6 0.52
Thyroid diameter (mm) 20.3  1.1 16.3  11.8 0.04
AP/TR (1/<1) 27/240 20/21 <0.01
Boundary (regular/irregular) 163/104 6/35 <0.01
Internal echo (homo/hetero) 158/109 7/34 <0.01
Echogenicity (hypo/iso) 218/49 33/8 0.86
Calcification (absent/present) 226/41 12/29 <0.01
Architecture (solid/cyst) 142/125 37/4 <0.01
Intra-nodular vascularity (marked/absent) 66/201 17/24 0.02
Elastography [(1/2)/(3/4)] 74/193 3/38 <0.01
AP/TR diameter Z anteroposterior/transverse diameter; US Z ultrasound; USE Z ultrasound elastography.
Table 2 Univariate and multivariate logistic regression analyses.
Univariate analysisa Multivariate analysis
OR 95% CI p OR 95% CI p
Thyroid diameter (mm) 1.0 1.0e1.0 0.8 db
AP/TR (1/<1) 8.3 4.0e17.4 <0.01 3.8 1.6e9.1 <0.01
Boundary (regular/irregular) 9.1 3.7e22.4 <0.01 2.1 0.7e6.5 0.2
Internal echo (homo/hetero) 7.1 3.0e16.5 <0.01 2.6 0.9e7.4 0.1
Calcification (absent/present) 13.8 6.5e29.6 <0.01 5.6 2.3e13.7 <0.01
Architecture (solid/cyst) 8.8 3.0e25.6 <0.01 2.2 0.7e7.5 0.2
Intranodular vascularity (marked/absent) 2.3 1.1e4.5 0.0 2.3 0.9e5.4 0.1
Elastography [(1/2)/(3/4)] 4.7 1.4e15.9 0.0 4.0 1.1e15.1 0.0
AP/TR diameter Z anteroposterior/transverse diameter.
a Age and sex adjusted.
b Not included in the multivariate analysis.
150 Y.-C. Chang et al.In our study, USE is an independent factor after adjust-
ing for sex, age, and other significant predictors in
conventional B-mode and color Doppler ultrasound exami-
nations. We suggest that in the differentiation of thyroid
nodules, the results of conventional US and USE should be
considered.
According to Bhatia et al [10], cystic change was a
confounding factor for real-time qualitative thyroid USE.
During the performance of USE, we noticed that thyroid
nodules with obvious cystic changes had higher RTE scores.
Because of the exclusion of nodules with nondiagnostic
cytology, most purely cystic nodules were excluded in this
study. We suggest that cystic change was a potential con-
founding factor, which should be noticed by the operator
during the performance of USE.
The following limitations should be addressed. We only
recruited cytology with a rating on the Bethesda system of
Thy 2, Thy 5, and Thy 6. There was no formal pathology
confirmation for these thyroid nodules. USE is a semi-
quantitative measurement, and SWE is more objective andmight be more accurate. Further rigorous investigation of
SWE in the clinical use of elastography in thyroid nodules is
warranted.Conclusion
Our study supports the hypothesis that USE is an indepen-
dent factor in determining malignant thyroid nodules.Acknowledgments
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